SB, W., T, W., M, H., JJ, M., RA, B., E, K., . . . TE, W. (2020). Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press.
Style de citation Chicago (17e éd.)SB, Wigal, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, et Wilens TE. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)SB, Wigal, et al. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.